Ibandronate Sodium Tablet, Film Coated
Product Images NDC 65862-237

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 65862-237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (Blister Carton (Three 150 mg Tablets = Three-month supply))

Outer carton label for Ibandronate Sodium Tablets 150 mg film-coated tablets in a package of 3 tablets, representing a three-month supply of once-monthly dosage. The label includes distribution information by Aurobindo Pharma USA, Inc., with the product made in India. It features dosage storage instructions, usage directions, and a unit-of-use blister with dated months for tracking tablet administration.*

FDA Label Image

Ibandronate Structure (Ibandronate Str)

Chemical structure diagram of Ibandronate Sodium showing the molecular arrangement including phosphonate groups and side chains, representing the active ingredient used in this drug product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.